Chemkart India, a Mumbai-based company known for its nutritional, health, and sports supplement products, is launching its Initial Public Offering (IPO) on July 7, 2025. The company is aiming to raise ₹80.08 Crores through a Book Built Issue, comprising a Fresh Issue of 26.00 Lakh Shares worth ₹64.48 Crores and an Offer for Sale (OFS) of 6.29 Lakh Shares worth ₹15.60 Crores. The Chemkart India IPO subscription will remain open till July 9, 2025, and is expected to list on the BSE SME platform on July 14, 2025.

The IPO price band is fixed between ₹236 and ₹248 per equity share. At the upper price band of ₹248, the estimated market capitalisation of Chemkart India Limited will stand at ₹300.05 Crores. The lot size is fixed at 600 shares, with a minimum investment amount of ₹1,48,800 for retail investors and ₹2,97,600 for HNIs (2 lots).

The IPO is managed by Smart Horizon Capital Advisors Private Limited as the Book Running Lead Manager, Bigshare Services Pvt Limited as the Registrar, and Alacrity Securities Limited as the Market Maker.

Chemkart India has already raised ₹22.60 Crores from Anchor Investors by allotting 9,11,400 equity shares at ₹248 per share, indicating strong institutional interest. This allocation was done in consultation with the book-running lead manager and is sourced from the Qualified Institutional Buyers (QIBs) portion.

The Grey Market Premium (GMP) for the Chemkart India IPO is reported at ₹22, indicating an 8.87% premium over the upper IPO price band, suggesting likely listing gains for investors. However, GMP is not an official indicator and may not reflect the actual market price on listing day. It is purely speculative and should be viewed for educational purposes only.

About the Company: Chemkart India

Chemkart India operates as a one-stop destination for nutritional, health, and sports supplement products, focusing on nutraceuticals that offer both nutritional and health benefits. Their portfolio includes a diverse array of products across seven key categories:

• Amino Acids

• Health Supplements

• Herbal Extracts

• Nucleotides

• Proteins

• Sports Nutrition

• Vitamins

These offerings make Chemkart a leading player in the Indian nutraceutical segment, catering to both domestic and international markets. Based in Mumbai, the company plans to expand operations by investing in manufacturing capacity and other capital-intensive projects through the proceeds of this IPO.

IPO Objectives

Chemkart India plans to utilise the net proceeds from the Fresh Issue for the following purposes:

• ₹3,468.33 Lakhs will be used for setting up a manufacturing facility through investment in its wholly owned subsidiary – Easy Raw Materials Private Limited.

• ₹2,000.00 Lakhs will be allocated for the repayment/prepayment of certain borrowings.

• The remaining funds will be used for general corporate purposes, which will support the company’s growth and operational expansion.

Company Promoters and Management

The IPO is backed by first-generation entrepreneurs including Mr. Ankit Shailesh Mehta, Ms. Parul Shailesh Mehta, and Mr. Shailesh Vinodrai Mehta. Mr. Ankit and Ms. Parul bring 4 and 9 years of experience, respectively, in the nutraceutical industry. Their leadership has helped Chemkart India evolve into a well-known brand within the supplement and health products space.

Financial Performance Overview

The company has shown strong financial growth over the last three years:

• FY 2022-23 Revenue: ₹13,168.62 Lakh

• FY 2023-24 Revenue: ₹13,282.77 Lakh

• FY 2024-25 Revenue: ₹20,545.63 Lakh

A similar upward trend is visible in other key financial indicators:

• EBITDA for FY25: ₹3,494.10 Lakh (up from ₹2,171.29 Lakh in FY24)

• Profit After Tax for FY25: ₹2,425.75 Lakh (up from ₹1,451.82 Lakh in FY24)

Valuation and Key Metrics

Chemkart India’s IPO seems fairly priced when viewed through its financial ratios:

• Pre-Issue EPS (FY24): ₹25.54

• Post-Issue EPS (FY24): ₹20.05

• Pre-Issue P/E Ratio: 9.71x

• Post-Issue P/E Ratio: 12.37x

• Return on Capital Employed (ROCE): 49.00%

• Return on Equity (ROE): 59.00%

• Return on Net Worth (RoNW): 45.52%

These numbers suggest that Chemkart is not only profitable but also efficient in capital utilisation, which can translate into shareholder value creation.

IPO Allotment & Listing Details

• IPO Opens: July 07, 2025

• IPO Closes: July 09, 2025

• Allotment Date: July 10, 2025 (Thursday)

• Listing Date: Tentatively July 14, 2025 (Monday)

• Stock Exchange: BSE SME

To check the allotment status, investors will be required to visit the registrar’s website (Bigshare Services Pvt Ltd) and follow these steps:

1. Select Chemkart India Limited IPO from the dropdown

2. Enter your application number, PAN, or DP Client ID

3. Click on Submit to view your status

This process will allow investors to track their investment status and act accordingly.

IPO Review and Recommendation

Based on the company’s consistent growth, healthy profit margins, moderate pricing, and strong GMP trends, the Chemkart India IPO could offer listing gains, particularly for risk-tolerant investors. However, since it is listed on the BSE SME platform, investors should also consider the illiquidity risk typically associated with SME stocks.

Analysts recommend that Risk-seeking investors may Apply for potential listing benefits, especially given the 8.87% GMP premium, rising financials, and positive market sentiment around the nutraceutical sector.

Investors must understand that GMPs are unofficial and speculative in nature. Therefore, decisions should be made with adequate due diligence, preferably in consultation with a SEBI-registered financial advisor.

Disclaimer:
The content provided in this article is meant solely for educational and informational purposes. It should not be treated as financial advice or an offer to buy/sell securities. All investment decisions should be made based on individual risk appetite and in consultation with certified professionals. Investment in securities is subject to market risks. Read all related documents carefully before investing.

The Upcoming IPOs in this week and coming weeks are CFF Fluid Control, Smarten Power Systems, Glen Industries, Travel Food Services, Anthem Biosciences, Chemkart India, Meta Infotech.

The Current active IPO are Happy Square Outsourcing Services, Cryogenic OGS, Crizac.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.